Rubric Capital Management LP Merrimack Pharmaceuticals Inc Transaction History

Rubric Capital Management LP

$3.59 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 13, 2019	SELL	$2.95 - $4.15 $1.64 Million - $2.3 Million	-554,338 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.91 - $4.66 $305,660 - $364,290	78,174 Added 16.42%	554,338 $2.96 Million
Q1 2018 May 14, 2018	BUY	$6.24 - $9.15 $411,340 - $603,168	65,920 Added 16.07%	476,164 $3.83 Million
Q4 2017 Feb 14, 2018	BUY	$7.99 - $11.87 $578,284 - $859,103	72,376 Added 21.42%	410,244 $4.21 Million
Q3 2017 Nov 13, 2017	BUY	$9.13 - $11.72 $3.08 Million - $3.96 Million	337,868	337,868 $4.91 Million

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.